PEPFAR support for the scaling up of collaborative TB/HIV activities

Journal of Acquired Immune Deficiency Syndromes

Volumn 60, Issue SUPPL.3, 2012, Pages

  Howard, Andrea A ^a   Gasana, Michel ^b   Getahun, Haileyesus ^c   Harries, Anthony ^d,e   Lawn, Stephen D ^e,f   Miller, Bess ^g   Nelson, Lisa ^h   Sitienei, Joseph ⁱ   Coggin, William L ^j  

^a Columbia University ^*  (United States)

^b RWANDA BIOMEDICAL CENTER   (Rwanda)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f UNIVERSITY OF CAPE TOWN   (South Africa)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ Division of Leprosy TB and Lung Disease   (Kenya)

^j US President's Emergency Plan for AIDS Relief   (United States)

more..

Author keywords

Collaborative TB HIV activities; HIV AIDS; President's Emergency Plan for AIDS Relief; Sub Saharan Africa; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; ISONIAZID;

AFRICA; ARTICLE; CD4+ T LYMPHOCYTE; DIAGNOSTIC TEST; EMERGENCY HEALTH SERVICE; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTEGRATION; LABORATORY; META ANALYSIS (TOPIC); MOLECULAR DIAGNOSIS; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATIENT COUNSELING; PATIENT GUIDANCE; PRESIDENT EMERGENCY PLAN FOR AIDS RELIEF; PREVALENCE; PRIORITY JOURNAL; SCALE UP; SCREENING TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL; VIRUS DNA CELL DNA INTERACTION; WORLD HEALTH ORGANIZATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA SOUTH OF THE SAHARA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; COMMUNICABLE DISEASE CONTROL; DEVELOPING COUNTRIES; HUMANS; INTERNATIONAL COOPERATION; NATIONAL HEALTH PROGRAMS; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; TUBERCULOSIS; UNITED STATES; WORLD HEALTH;

EID: 84866078656     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31825cfe8e     Document Type: Article

References (77)

1. Getahun H, Gunneberg C, Granich R, et al. HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis. 2010;50(suppl 3):S201-S207.
2. World Health Organization. Global tuberculosis control: WHO report 2011. Geneva, Switzerland: WHO; 2011.
3. World Health Organization. WHO Policy on Collaborative TB/HIV Activities: Guidelines for National Programmes and Other Stakeholders. Geneva, Switzerland: WHO; 2012.
4. The U. S. President's Emergency Plan for AIDS Relief. Technical considerations provided by PEPFAR technical working groups for FY 2012 COPS and ROPS. Available at: http://www.pepfar.gov/documents/organization/169737.pdf. Accessed June 4, 2012.
5. Stop TB Parternship. Accelerating the Implementation of Collaborative HIV/TB Activities in Selected sub-Saharan African Countries [meeting report]. 2007. Available at: http://www.stoptb.org/wg/tb-hiv/assets/documents/ Meeting%20report.pdf. Accessed June 4, 2012.
6. World Health Organization. WHO Three I's Meeting Report. Intensified Case Finding (ICF), Isoniazid Preventive Therapy (IPT) and TB Infection Control (IC) for people living with HIV. Geneva, Switzerland: WHO; 2008.
7. Havlir DV, Getahun H, Sanne I, et al. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA. 2008;300:423-430.
8. Howard AA, El-Sadr WM. Integration of tuberculosis and HIV services in sub-Saharan Africa: lessons learned. Clin Infect Dis. 2010;50(suppl 3):S238-S244.
9. Uyei J, Coetzee D, Macinko J, et al. Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa: a systematic review. Lancet Infect Dis. 2011;11:855-867.
10. Getahun H, Scano F, Nunn P. Implementation of collaborative tuberculosis/HIV activities: policy and programmatic issues. In: Schaaf HS, Zumla AI, eds. Tuberculosis: A Comprehensive Clinical Reference. Philadelphia, PA: Saunders/Elsevier; 2009.
11. World Health Organization. A Guide to Monitoring and Evaluation for Collaborative TB/HIV Activities. Geneva, Switzerland: WHO, UNAIDS and OGAC. WHO/HTM/TB/2009.414, WHO/HTM/HIV; 2009.
12. World Health Organization. Three Interlinked Patient Monitoring Systems for HIV care/ART, MCH/PMTCT and TB/HIV: Standardized Minimum Data Set and Illustrative Tools. Geneva: WHO, 2009.
13. World Health Organization Department of HIV/AIDS, Joint United Nations Programme on HIV/AIDS. Guidance on Provider-Initiated HIV Testing and Counseling in Health Facilities. Geneva, Switzerland: WHO, UNAIDS; 2007.
14. Bock NN, Nadol P, Rogers M, et al. Provider-initiated HIV testing and counseling in TB clinical settings: tools for program implementation. Int J Tuberc Lung Dis. 2008;12:S69-S72.
15. Gunneberg C, Sculier D, Reid A, et al. Comparison of progress in provision of HIV testing and ART for TB patients-African region, the rest of the world and PEPFAR supported countries. Presented at: 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; 2011; Rome, Italy. Abstract TUPE485.
16. Coggin WL, Ryan CA, Holmes CB. Role of the US President's Emergency Plan for AIDS Relief in responding to tuberculosis and HIV coinfection. Clin Infect Dis. 2010;50(suppl 3):S255-S259.
17. Van Rie A, Sabue M, Jarrett N, et al. Counseling and testing TB patients for HIV: evaluation of three implementation models in Kinshasa, Congo. Int J Tuberc Lung Dis. 2008;12:S73-S78.
18. Pevzner ES, Vandebriel G, Lowrance DW, et al. Evaluation of the rapid scale-up of collaborative TB/HIV facilities in Rwanda, 2005-2009. BMC Public Health. 2011;11:550.
19. Corneli A, Jarrett NM, Sabue M, et al. Patient and provider perspectives on implementation models of HIV counseling and testing for patients with TB. Int J Tuberc Lung Dis. 2008;12:S79-S84.
20. Sitieni J, Kipruto H, Nganga, et al. HIV testing and treatment among tuberculosis patients-Kenya, 2006-2009. MMWR Morb Mortal Wkly Rep. 2010;59:1514-1517.
21. Mwinga A, Mwananyambe N, Kaneme C, et al. Provider-initiated HIV testing and counseling of TB patients-Livingstone District, Zambia, September 2004-December 2006. MMWR Morb Mortal Wkly Rep. 2008;57:285-289.
22. Currie CS, Williams BG, Cheng RC, et al. Tuberculosis epidemics driven by HIV: is prevention better than cure? AIDS. 2003;17:2501-2508.
23. World Health Organization. Guidelines for the Prevention of Tuberculosis in Health Care Facilities in Resource-Limited Settings. Geneva, Switzerland: WHO; 1999. WHO/CDS/TB/99 269.
24. World Health Organization. Preventive therapy against tuberculosis in people living with HIV. Policy Statement. Wkly Epidemiol Rec. 1999;74:385-400.
25. Getahun H, Kittikraisak AW, Heilig CM, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med. 2011;8:e1000391.
26. The U. S. President's Emergency Plan for AIDS Relief. PEPFAR Annual Progress Report. Washington, D. C.: Office of the Global AIDS Coordinator; 2010.
27. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006;368:1575-1580.
28. Joshi R, Reingold AL, Menzies D, et al. Tuberculosis among health-care workers in low-and midle-income countries: a systematic review. PLoS Med. 2006;3:e494.
29. World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report 2006. Geneva, Switzerland: WHO; 2006.
30. World Health Organization, Centers for Disease Control and Prevention. Tuberculosis Infection Control in the Era of Expanding HIV Care and Treatment: An Addendum to WHO Guidelines for the Prevention of Tuberculosis in Health Care Facilities in Resource-Limited Settings. Atlanta, GA: CDC; 2006.
31. World Health Organization. WHO Policy on TB Infection Control in Health-Care Facilities, Congregate Settings and Households. Geneva, Switzerland: WHO/HTM/TB/ 2009. 419; 2009.
32. Republic of Ghana Ministry of Health. Standard Operating Procedures for TB and Airborne Infection Prevention and Control in Ghana. Accra, Ghana: Republic of Ghana Ministry of Health; 2010.
33. Verkuijl S, Maharaj S, Jagwer G, et al. TB infection control in resourcelimited settings in the era of expanding HIV care and treatment: lessons learnt from the Eastern Cape, South Africa [abstract 492]. Presented at: Programs and Abstracts of the 4th South African AIDS Conference; 2009; Durban, South Africa.
34. Nakashima A, Lipke V, Emerson C, et al. Implementing TB Infection Control in outpatient settings: a training and implementation package. Centers for Disease Control and Prevention and Zambian Ministry of Health. 2012. Available at: http://www.cdc.gov/globalaids/Resources/pmtct-care/tuberculosis-infection- control.html. Accessed June 4, 2012.
35. Parsons L, Somoskovi A, Gutierrez C, et al. Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities. Clin Microbiol Rev. 2011;24:314-350.
36. Nkengasong J, Nsuguba P, Nwanyanwu O, et al. Laboratory systems and services are critical in global health: time to end the neglect? Am J Clin Pathol. 2012;134:373.
37. Lawn SD, Wood R, De Cock KM, et al. Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources. Lancet Infect Dis. 2010;10:489-498.
38. Middelkoop K, Bekker LG, Myer L, et al. Antiretroviral program associated with reduction in untreated prevalent tuberculosis in a South African township. Am J Respir Crit Care Med. 2010;182:1080-5.
39. Zachariah R, Bemelmans M, Akesson A, et al. Reduced tuberculosis notification associated with scaling up antiretroviral treatment in rural Malawi. Int J Tuberc Lung Dis. 2011;15:933-937.
40. Lawn SD, Fraenzel A, Kranzer K, et al. Provider-initiated HIV testing increases access of patients with HIV-associated tuberculosis to antiretroviral treatment. S Afr Med J. 2011;101:258-262.
41. Boulle A, Van CG, Hilderbrand K, et al. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS. 2010;24:563-572.
42. Lawn SD, Harries AD, Williams BG, et al. Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it? Int J Tuberc Lung Dis. 2011;15:571-581.
43. The United States Government Global Health Initiative Strategy. 2012. Available at: http://www.pepfar.gov/documents/organization/136504.pdf. Accessed June 4, 2012.
44. Smart T. TB and HIV in practice. HIV & AIDS Treatment in Practice. September 2011:181.
45. Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Sys Rev. 2010; CD000171.
46. World Health Organization. Guidelines for Intensifed Tuberculosis Case-Finding and Isoniazid Preventive Therapy for People Living With HIV in Resource-Constrained Settings. Geneva, Switzerland: WHO; 2010.
47. Golub JE, Saraceni V, Cavalcante SC, et al. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS. 2007;21:1441-1448.
48. Golub JE, Pronyk P, Mohapi L, et al. Isoniazid preventive therapy, HAART, and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS. 2009;23:631-636.
49. Date AA, Vitoria M, Granich R, et al. Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV. Bull World Health Organ. 2010;88:253-259.
50. Getahun H, Granich R, Sculier D, et al. Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions. AIDS. 2010;24:S57-S65.
51. Lester R, Hamilton R, Charalambous S, et al. Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study. AIDS. 2010;24:S45-S48.
52. Balcells ME, Thomas SL, Godfrey-Faussett P, et al. Isoniazid preventive therapy and risk for resistant tuberculosis. Emerg Infect Dis. 2006;12:744-751.
53. Stop TB Parternship. The Global Plan to Stop TB 2011-2015. Geneva, Switzerland: World Health Organization; 2011.
54. Lawn SD, Wood R. Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis. J Infect Dis. 2011;204(suppl 4):S1159-S1167.
55. Reid MJ, Shah NS. Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis. 2009;9:173-184.
56. Lawn SD, Nicol MP. Xpert (R) MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol. 2011;6:1067-1082.
57. World Health Organization. Rapid Implementation of the Xpert MTB/RIF Diagnostic Test. Geneva, Switzerland: WHO; 2011.
58. The U. S. President's Emergency Plan for AIDS Relief (PEFPAR), US Agency for International Development and US Department of Health and Human Services. US Global Health Programs Welcome World Health Organization Endorsement of Rapid Test for Tuberculosis. 2010. Available at: http://www.pepfar.gov/press/releases/ 2010/152541.htm. Accessed June 4, 2012.
59. Ackah AN, Coulibaly D, Digbeu H, et al. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Cote d'Ivoire. Lancet. 1995;345:610.
60. Perriens JH, St Louis ME, Mukadi YB, et al. Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. N Engl J Med. 1995;332:779-784.
61. Diul MY, Maher D, Harries AD. Tuberculosis case fatality rates in HIV prevalence populations in sub-Saharan Africa. AIDS. 2001;15:152.
62. Harries AD, Hargreaves NJ, Gausi F, et al. High early death rate in tuberculosis patients in Malawi. Int J Tuberc Lung Dis. 2001;5:1000-1005.
63. Blanc FX, Sok T, Laureillard D, et al. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med. 2011;365:1471-1481.
64. Havlir DV, Kendall MA, Ive P, et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011;365:1482-1491.
65. Abdool Karim SS, Naidoo K, Grobler A, et al. Integration of antiretroviral therapy with tuberculosis treatment. N Engl J Med. 2011;365:1492-1501.
66. Lowrance DW, Makombe S, Harries A, et al. Lower early mortality rates among patients receiving antiretroviral treatment at clinics offering cotrimoxazole prophylaxis in Malawi. J Acquir Immune Def Syndr. 2007;46:56-61.
67. Marais B, Rabie H, Cotton M. TB and HIV in children-advances in prevention and management. Paed Respir Rev. 2011;12:39-45.
68. Nicol M, Zar H. New specimens and laboratory diagnostics for childhood TB: progress and prospects. Paediatr Respir Rev. 2011;12:16-21.
69. Hawkridge T, Mahomed H. Prospects for a new, safer and more effective TB vaccine. Paediatr Respir Rev. 2011;12:46-51.
70. du Cros P, Bern-Thomas N, Gale M, et al. Counting children: comparing reporting for paediatric HIV and tuberculosis. Bull World Health Organ. 2011;89:855.
71. Padian NS, Holmes CV, McCoy SI, et al. Implementation science for the US President's Emergency Plan for AIDS Relief (PEPFAR). J Acquir Immune Def Syndr. 2011;56:199-203.
72. Programme-National-Integre-de-Lutte-contre-la-Lepre-et-la-Tuberculose. Rapport annuel d'activites 2005. Kigali, Rwanda: Rwanda Ministry of Health; 2005.
73. Programme-National-Integre-de-Lutte-contre-la-Lepre-et-la-Tuberculose. Rapport annuel d'activites 2006. Kigali, Rwanda: Rwanda Ministry of Health; 2006.
74. Tuberculosis Unit-TRACPlus. Handbook of Tuberculosis and TB/HIV in Rwanda. Kigali, Rwanda: Rwanda Ministry of Health; 2009.
75. Tuberculosis Unit-TRACPlus. Report d'activites pour l'annee 2009. Kigali, Rwanda: Rwanda Ministry of Health; 2009.
76. Tuberculosis Unit-TRACPlus. Annual Report (January-December 2010). Tuberculosis and Respiratory Communicable Diseases Division/IHDPC/RBC/MOH. Kigali, Rwanda: Rwanda Ministry of Health; 2011:37.
77. Tuberculosis and Respiratory Communicable Diseases Division/IHDPC/RBC/ MOH. Quarterly report (October-December 2011). Kigali, Rwanda: Rwanda Ministry of Health; 2011:36.